TG Therapeutics, Inc.
TGTX
$33.59
$0.190.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 276.24M | 311.00M | 341.04M | 217.25M | 209.79M |
| Total Receivables | 190.12M | 129.19M | 115.73M | 83.61M | 64.98M |
| Inventory | 157.76M | 110.46M | 84.67M | 81.24M | 77.72M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.39M | 15.72M | 32.63M | 7.05M | 8.10M |
| Total Current Assets | 644.51M | 566.36M | 574.07M | 389.15M | 360.58M |
|
|
|||||
| Total Current Assets | 644.51M | 566.36M | 574.07M | 389.15M | 360.58M |
| Net Property, Plant & Equipment | 6.93M | 7.15M | 7.41M | 7.66M | 7.97M |
| Long-term Investments | -- | -- | -- | -- | 799.00K |
| Goodwill | -- | -- | -- | -- | 799.00K |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.35M | 3.37M | 3.41M | 3.45M | 2.65M |
| Total Assets | 656.69M | 577.69M | 586.01M | 401.21M | 373.32M |
|
|
|||||
| Total Accounts Payable | 64.33M | 26.30M | 77.01M | 71.87M | 72.27M |
| Total Accrued Expenses | 5.14M | 15.19M | 10.09M | 6.35M | 3.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.99M | 1.82M | 1.23M | 1.69M | 1.71M |
| Total Finance Division Other Current Liabilities | 88.75M | 47.38M | 36.79M | 28.75M | 22.12M |
| Total Other Current Liabilities | 88.75M | 47.38M | 36.79M | 28.75M | 22.12M |
| Total Current Liabilities | 160.21M | 90.68M | 125.11M | 108.66M | 99.68M |
|
|
|||||
| Total Current Liabilities | 160.21M | 90.68M | 125.11M | 108.66M | 99.68M |
| Long-Term Debt | 244.73M | 244.43M | 244.16M | 102.54M | 101.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.86M | 8.13M | 8.42M | 8.70M | 8.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.60M | 12.09M | 16.17M | 3.74M | 3.24M |
| Total Liabilities | 419.40M | 355.33M | 393.86M | 223.64M | 213.21M |
|
|
|||||
| Common Stock & APIC | 1.78B | 1.76B | 1.75B | 1.73B | 1.69B |
| Retained Earnings | -1.52B | -1.53B | -1.55B | -1.56B | -1.53B |
| Treasury Stock & Other | -15.12M | -8.99M | -2.38M | -234.00K | -234.00K |
| Total Common Equity | 237.29M | 222.36M | 192.16M | 177.57M | 160.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 237.29M | 222.36M | 192.16M | 177.57M | 160.11M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 237.29M | 222.36M | 192.16M | 177.57M | 160.11M |
|
|
|||||